Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial
O'Connor, Owen A, Lue, Jennifer K, Sawas, Ahmed, Amengual, Jennifer E, Deng, Changchun, Kalac, Matko, Falchi, Lorenzo, Marchi, Enrica, Turenne, Ithamar, Lichtenstein, Renee, Rojas, Celeste, FrancesconМова:
english
Журнал:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30912-9
Date:
December, 2017
Файл:
PDF, 438 KB
english, 2017